← BMJ Neurology Open

Papers in BMJ Neurology Open

Page 2 · newest first

51. A mixed-methods study of patient perspectives on antiseizure medication discontinuation attempts after a period of seizure-freedomBMJ Neurology Open · 2026
52. Suicidal behaviour and suicide mortality in Parkinson’s disease: a nationwide register-based cohort studyBMJ Neurology Open · 2026
53. Head trauma and environment progression of amyotrophic lateral sclerosis: long-term data from the National ALS RegistryBMJ Neurology Open · 2026
54. Associations of chrononutrition and sleep with fatigue in multiple sclerosis: an analysis of the Swiss Multiple Sclerosis RegistryBMJ Neurology Open · 2026
55. Impact of X-linked dystonia-parkinsonism on caregiver strain, anxiety and depressionBMJ Neurology Open · 2026
56. Age-specific and time-dependent trends in health-related quality of life after minor stroke: results of a cross-sectional cohort studyBMJ Neurology Open · 2026
57. Impact of bariatric surgery on headache frequency and severity and quality of life in patients with migraine: a prospective studyBMJ Neurology Open · 2026
58. Same-territory chronic infarcts are common in intracranial atherosclerosis and are associated with future recurrenceBMJ Neurology Open · 2026
59. Prospective Evaluation of the Neurology Same Day Emergency Care (NeuroSDEC) Model in Secondary Care: data from 931 patients over the first 12 monthsBMJ Neurology Open · 2026
60. Longitudinal Orthostatic Tremor Study (LOTS): a multi-centre, prospective cohort protocol for characterising orthostatic tremor and orthostatic myoclonusBMJ Neurology Open · 2026
61. Predicting the outcome of specialist rehabilitation after non-traumatic subarachnoid haemorrhage: a multicentre cohort analysis from the UK Rehabilitation Outcomes Collaborative (UKROC) databaseBMJ Neurology Open · 2026
62. Association between angiotensin receptor blocker use and postmortem dementia pathology: analysis of the UK Brain Banks Network datasetBMJ Neurology Open · 2026
63. Inclusive approaches to research and healthcare for nitrous oxide users: lessons from a longitudinal studyBMJ Neurology Open · 2026
64. Plasma CHI3L1 as a marker of cognitive and structural brain changes in radiologically isolated syndromeBMJ Neurology Open · 2026
65. Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosisBMJ Neurology Open · 2026
66. Screening for mood disorders after stroke: feasibility of a community-based pathwayBMJ Neurology Open · 2026
67. Bilateral thalamic involvement in scrub typhus meningoencephalitis: a case report of an uncommon neuroimaging pattern mimicking Japanese encephalitisBMJ Neurology Open · 2026
68. Comprehensive evaluation of telehealth outpatient stroke service in rural and remote Australia: a multicentre study protocolBMJ Neurology Open · 2026
69. Chorea-acanthocytosis masquerading as a progressive seizure disorder with apparent early immunotherapy responsivenessBMJ Neurology Open · 2026
70. Two phase 1 randomised studies investigating the safety and pharmacokinetics of bepranemab in healthy participants of different ethnicitiesBMJ Neurology Open · 2026
71. Peripheral frataxin levels govern long-term clinical progression in Friedreich ataxiaBMJ Neurology Open · 2026
72. Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumabBMJ Neurology Open · 2026
73. Neurological implications of chimeric antigen receptor-T cell therapyBMJ Neurology Open · 2026
74. Exploring transient global amnesia: a 14-year retrospective study of 142 casesBMJ Neurology Open · 2026
75. At the extreme limits of L-DOPA therapy: probable dopamine dysregulation and psychiatric complications in Parkinson’s diseaseBMJ Neurology Open · 2026
76. Effect of deep brain stimulation on patients with Parkinson’s disease with mild cognitive impairmentBMJ Neurology Open · 2026
77. Tolerating uncertainty to treat functional motor disorderBMJ Neurology Open · 2026
78. Clinical profile and treatment outcomes of patients with chronic presentations of autoimmune encephalitis: expanding the spectrumBMJ Neurology Open · 2026
79. Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian studyBMJ Neurology Open · 2026
80. United Kingdom Young Stroke Study (UKYSS): study protocol for an ambispective observational studyBMJ Neurology Open · 2026
81. Hallucinations and cognitive impairment are associated with blood pressure fluctuations in Parkinson’s diseaseBMJ Neurology Open · 2026
82. Guide to developing research recruitment strategies with the expertsBMJ Neurology Open · 2026
83. Poststroke fatigue in subacute and chronic stroke rehabilitation phase: prevalence, associated factors and impact on self-efficacy and functional abilityBMJ Neurology Open · 2026
84. When images come to life: a case seriesBMJ Neurology Open · 2026
85. Increased susceptibility and volume reduction in deep brain nuclei in primary orthostatic tremorBMJ Neurology Open · 2026
86. ¹⁸ F-DPA-714 PET/MRI reveals early and widespread neuroinflammation in sporadic Creutzfeldt–Jakob disease: a case reportBMJ Neurology Open · 2026
87. Safety, tolerability and biomarker results of bepranemab in participants with progressive supranuclear palsy: a randomised, multicentre, double-blind, placebo-controlled, phase 1b trialBMJ Neurology Open · 2026
88. Mapping end-of-life care for patients with neurological conditions in German hospices: a point prevalence surveyBMJ Neurology Open · 2026
89. Neurophobia among the Egyptian early-career physicians: the first national multi-centre reportBMJ Neurology Open · 2026
90. Perinatal, neurodevelopmental and childhood health factors in patients with functional neurological disorder: a retrospective case-record study in a tertiary neuropsychiatry cohortBMJ Neurology Open · 2026
91. Predicting cancer aetiology in patients with stroke using brain imaging aloneBMJ Neurology Open · 2026
92. PM 2.5 and black carbon associated with acute ischaemic stroke: an ecological studyBMJ Neurology Open · 2026
93. High-income country-supported telestroke thrombolysis to a lower–middle income country: an international proof-of-concept case reportBMJ Neurology Open · 2026
94. Bi-allelic intermediate ATXN2 repeat expansions are associated with slow progressing, leg-onset familial ALSBMJ Neurology Open · 2026
95. Aotearoa New Zealand’s neurologist workforce: a 2024 analysis of demand, supply and projectionsBMJ Neurology Open · 2026
96. Reduced intracortical inhibition and enhanced intracortical facilitation in patients with functional tremorBMJ Neurology Open · 2026
97. Non-invasive electrodiagnostic testing for small fibre neuropathy in long COVID-19BMJ Neurology Open · 2026
98. Seizure burden and treatment efficacy evaluation in anti-LGI1 autoimmune encephalitis patients using wearable device: a pilot feasibility studyBMJ Neurology Open · 2026
99. Exploring cardiac autonomic dysfunction in synucleinopathies with parkinsonism through awake–sleep stages: a possible connection to cardiovascular deathBMJ Neurology Open · 2026
100. Deep brain stimulation for Parkinson’s disease in Thailand: cost, utility and policy implications for universal health coverageBMJ Neurology Open · 2026